LANARI, Manuela
LANARI, Manuela
Dip. STORIA (attivo dal 01/01/1900 al 31/12/2012)
Children and coronavirus: The necessary search for a balance between the alleged risks and documented collateral damage
2020-01-01 Tamburlini G.; Marchetti F.; Bertino E.; Bestetti G.; Biasucci G.; Biondi A.; Bonati M.; Brunelli A.; Corsello G.; Esposito S.; Fagioli F.; Farina D.; Gagliardi L.; Gangemi M.; Greco L.; Lanari M.; Lazzerini M.; Maggiore G.; Martelossi S.; Ramenghi U.; Piga A.; Selicorni A.; Spada M.; Ventura A.; Vicari S.; Zampino G.; Zanetto F.
QuantiFERON-TB performs better in children, including infants, than in adults with active tuberculosis: A multicenter study
2019-01-01 Lombardi G.; Pellegrino M.T.; Denicolo A.; Corsini I.; Tadolini M.; Bergamini B.M.; Meacci M.; Garazzino S.; Peracchi M.; Lanari M.; Re M.C.; Monte P.D.
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children
2025-01-01 Carbonell-Estrany, X; Simoes, EAF; Bont, L; Manzoni, P; Zar, HJ; Greenough, A; Ramilo, O; Stein, R; Law, B; Mejias, A; Luna, MS; Checchia, PA; Krilov, L; Lanari, M; Dagan, R; Fauroux, B; Resch, B; Heikkinen, T; Domachowske, JB; Wildenbeest, JG; Martinon-Torres, F; Thwaites, R; Cetinkaya, M; Alharbi, AS; Rodriguez-Martinez, CE; Noyola, DE; Kassim, A; Kusuda, S; Kang, JM; Rodgers-Gray, B; Platonova, A; Jah, F; Paes, B
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Children and coronavirus: The necessary search for a balance between the alleged risks and documented collateral damage | 2020 | Tamburlini G.; Marchetti F.; Bertino E.; Bestetti G.; Biasucci G.; Biondi A.; Bonati M.; Brunelli A.; Corsello G.; Esposito S.; Fagioli F.; Farina D.; Gagliardi L.; Gangemi M.; Greco L.; Lanari M.; Lazzerini M.; Maggiore G.; Martelossi S.; Ramenghi U.; Piga A.; Selicorni A.; Spada M.; Ventura A.; Vicari S.; Zampino G.; Zanetto F. | |
| QuantiFERON-TB performs better in children, including infants, than in adults with active tuberculosis: A multicenter study | 2019 | Lombardi G.; Pellegrino M.T.; Denicolo A.; Corsini I.; Tadolini M.; Bergamini B.M.; Meacci M.; Garazzino S.; Peracchi M.; Lanari M.; Re M.C.; Monte P.D. | |
| Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children | 2025 | Carbonell-Estrany, X; Simoes, EAF; Bont, L; Manzoni, P; Zar, HJ; Greenough, A; Ramilo, O; Stein, R; Law, B; Mejias, A; Luna, MS; Checchia, PA; Krilov, L; Lanari, M; Dagan, R; Fauroux, B; Resch, B; Heikkinen, T; Domachowske, JB; Wildenbeest, JG; Martinon-Torres, F; Thwaites, R; Cetinkaya, M; Alharbi, AS; Rodriguez-Martinez, CE; Noyola, DE; Kassim, A; Kusuda, S; Kang, JM; Rodgers-Gray, B; Platonova, A; Jah, F; Paes, B |